Advertisement
Screener

LivaNova PLC (LIVN) Investment Income, Net

2.3 / 5 stars · 53/116 Roast Me

LivaNova PLC Investment Income, Net

LivaNova PLC (LIVN) reported Investment Income, Net of $4.18 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-06.

Financial Statements › Income Statement › Other Income

us-gaap:InvestmentIncomeNet · last filed 2025-08-06

  • LivaNova PLC investment income, net for the quarter ending 2025-06-30 was $4.18M, a 42.99% decline year-over-year.
  • LivaNova PLC investment income, net for the quarter ending 2025-03-31 was $6.44M, a 8.23% decline year-over-year.
  • LivaNova PLC investment income, net for the quarter ending 2024-12-31 was $8.58M, a 42.33% increase year-over-year.
  • LivaNova PLC investment income, net for the quarter ending 2024-09-30 was $7.14M, a 20.57% increase year-over-year.
  • LivaNova PLC investment income, net for fiscal 2024 was $30.07M, a 36.63% increase from fiscal 2023.
  • LivaNova PLC investment income, net for fiscal 2023 was $22.01M, a 368.64% increase from fiscal 2022.
  • LivaNova PLC investment income, net for fiscal 2022 was $4.70M.
Period endInvestment Income, Net 3 monthInvestment Income, Net 6 monthInvestment Income, Net 9 monthInvestment Income, Net 12 month
2025-06-30$4.18M
10-Q · filed 2025-08-06
$10.63M
10-Q · filed 2025-08-06
$19.20M
derived: sum of 3 quarters · filed 2025-08-06
$26.34M
derived: sum of 4 quarters · filed 2025-08-06
2025-03-31$6.44M
10-Q · filed 2025-05-07
$15.02M
derived: sum of 2 quarters · filed 2025-05-07
$22.16M
derived: sum of 3 quarters · filed 2025-05-07
$29.50M
derived: sum of 4 quarters · filed 2025-08-06
2024-12-31$8.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
$15.72M
derived: sum of 2 quarters · filed 2025-02-25
$23.05M
derived: sum of 3 quarters · filed 2025-08-06
$30.07M
10-K · filed 2025-02-25
2024-09-30$7.14M
10-Q · filed 2024-10-31
$14.48M
derived: sum of 2 quarters · filed 2025-08-06
$21.50M
10-Q · filed 2024-10-31
$27.52M
derived: sum of 4 quarters · filed 2025-08-06
2024-06-30$7.34M
10-Q · filed 2025-08-06
$14.36M
10-Q · filed 2025-08-06
$20.39M
derived: sum of 3 quarters · filed 2025-08-06
$26.31M
derived: sum of 4 quarters · filed 2025-08-06
2024-03-31$7.02M
10-Q · filed 2025-05-07
$13.05M
derived: sum of 2 quarters · filed 2025-05-07
$18.97M
derived: sum of 3 quarters · filed 2025-05-07
$24.50M
derived: sum of 4 quarters · filed 2025-05-07
2023-12-31$6.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
$11.95M
derived: sum of 2 quarters · filed 2025-02-25
$17.48M
derived: sum of 3 quarters · filed 2025-02-25
$22.01M
10-K · filed 2025-02-25
2023-09-30$5.92M
10-Q · filed 2024-10-31
$11.45M
derived: sum of 2 quarters · filed 2024-10-31
$15.98M
10-Q · filed 2024-10-31
$20.06M
derived: sum of 4 quarters · filed 2025-02-25
2023-06-30$5.53M
10-Q · filed 2024-08-01
$10.06M
10-Q · filed 2024-08-01
$14.14M
derived: sum of 3 quarters · filed 2025-02-25
$14.68M
derived: sum of 4 quarters · filed 2025-02-25
2023-03-31$4.54M
10-Q · filed 2024-05-03
$8.61M
derived: sum of 2 quarters · filed 2025-02-25
$9.16M
derived: sum of 3 quarters · filed 2025-02-25
$9.21M
derived: sum of 4 quarters · filed 2025-02-25
2022-12-31$4.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
$4.62M
derived: sum of 2 quarters · filed 2025-02-25
$4.68M
derived: sum of 3 quarters · filed 2025-02-25
$4.70M
10-K · filed 2025-02-25
2022-09-30$547.00K
10-Q · filed 2023-11-01
$604.00K
derived: sum of 2 quarters · filed 2023-11-01
$624.00K
10-Q · filed 2023-11-01
2022-06-30$57.00K
10-Q · filed 2023-07-26
$77.00K
10-Q · filed 2023-07-26
2022-03-31$20.00K
10-Q · filed 2023-05-03
2021-09-30$178.00K
10-Q · filed 2022-11-02
$367.00K
derived: sum of 2 quarters · filed 2022-11-02
$293.00K
10-Q · filed 2022-11-02
2021-06-30$189.00K
10-Q · filed 2022-08-03
$115.00K
10-Q · filed 2022-08-03
2021-03-31-$74.00K
10-Q · filed 2022-05-04
2015-10-18-$85.79K
10-Q · filed 2015-12-08
-$60.94K
10-Q · filed 2015-12-08
2014-10-24$43.16K
10-Q · filed 2015-12-08
$80.82K
10-Q · filed 2015-12-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
Integer Holdings Corp (ITGR)United States$4.289B25.17
TransMedics Group, Inc. (TMDX)United States$2.911B15.17
Axogen, Inc. (AXGN)United States$2.329B-73.83
BIOLIFE SOLUTIONS INC (BLFS)United States$1.887B23.80
CONMED Corp (CNMD)United States$1.353B26.72
Ceribell, Inc. (CBLL)United States$0.916B-11.27
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53